ZAS

What ZAS does

ZAS Corporation Ltd. is a privately held pharmaceutical import and distribution company headquartered in Dhaka, Bangladesh, operating since approximately 1995 with an employee base in the 251–500 range. The company specializes in importing, marketing, selling, and distributing niche pharmaceutical molecules into the Bangladesh market, sourcing products from more than 70 global partners across 40+ countries including Germany, Japan, Switzerland, the United States, and others. Its core platform combines four integrated capabilities: a curated niche-molecule import portfolio backed by 300+ regulatory registrations in Bangladesh, ethical marketing targeted at healthcare professionals, Good Distribution Practice (GDP)-compliant temperature-controlled distribution, and WHO-standard pharmacovigilance and quality assurance services.

The company's go-to-market is a B2B enterprise field sales model with marketing and sales teams segmented by therapeutic area, selling to healthcare providers and institutions across Bangladesh. Revenue mechanics are based on one-time transactional distribution of imported pharmaceutical products rather than subscription or licensing arrangements; pricing is not publicly disclosed. ZAS operates under the ZAS Group umbrella with four wholly-owned subsidiaries — ZAS Pharma (pharmaceutical products), ZAS Industries (industrial products), ZAS Ophthalmic (ophthalmic products), and ZAS Communications (communications) — extending its footprint beyond core pharma distribution. Ownership is described as private/founder-controlled with no disclosed venture capital, private equity, or public market participation.

Name

ZAS

Legal name

ZAS Corporation Ltd.

Website

https://zascorporation.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

251–500 employees

Short description

ZAS Corporation is a private Bangladeshi pharmaceutical importer and distributor that sources niche molecules from 70+ global partners across 40+ countries and serves healthcare providers and institutions in Bangladesh with regulatory-registered, GDP-compliant distribution and pharmacovigilance services.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Ophthalmic Goods Merchant Wholesalers (42346)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Pharmaceutical distribution
• Niche molecule imports
• Pharmacovigilance services
• Medical device supply
• Healthcare distribution

Headquarters

HQ city

Dhaka

HQ country

Bangladesh

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Supply Chain, Technology or R&D

Revenue model

1. Pharmaceutical Import and Distribution: Import, marketing, sales, and distribution of pharmaceutical niche molecules. Revenue generated through distribution of specialized pharmaceutical products imported from global partners across 40+ countries.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

ZAS Corporation imports, markets, sells, and distributes pharmaceutical niche molecules and medical devices in Bangladesh, sourced through 70+ global partnerships across 40+ countries. The company holds 300+ product registrations in Bangladesh and supports its offerings with Good Distribution Practice (GDP)-compliant temperature-controlled distribution and WHO-standard pharmacovigilance services. Its operations are organized by segmented sales teams covering multiple therapeutic areas.

Product overview

ZAS Corporation operates as a pharmaceutical import, marketing, sales, and distribution company specializing in niche molecules in Bangladesh. The company functions as a unified platform offering four integrated core services: Niche Pharmaceutical Imports (curated selection of pharmaceutical molecules with 300+ registrations), Ethical Marketing Services (transparent communication to healthcare professionals), Good Distribution Practice (GDP) Services (temperature-controlled distribution with integrity and safety), and Pharmacovigilance Services (WHO-standard market monitoring for patient safety). The company also maintains multiple affiliate sub-brands including ZAS Pharma, ZAS Industries, ZAS Ophthalmic, and ZAS Communications, all under the ZAS Group umbrella.

Differentiator

Problem solved

Functional benefit

Brands

• ZAS Pharma: Pharmaceutical import and distribution subsidiary focusing on therapeutic areas and pharmaceutical niche molecules
• ZAS Industries
• ZAS Ophthalmic
• ZAS Communications

Products and services

• Niche Pharmaceutical Imports Curated import service providing a selection of specialized pharmaceutical niche molecules for the Bangladesh market, supported by 300+ product registrations in Bangladesh and partnerships with global pharmaceutical manufacturers.
• Ethical Marketing Services Transparent and responsible marketing services that communicate the benefits of niche pharmaceutical molecules to healthcare professionals and consumers in Bangladesh.
• Good Distribution Practice (GDP) Distribution Services Pharmaceutical distribution services adhering to Good Distribution Practice standards, with maintained temperature control, integrity, reliability, and safety throughout the distribution chain in Bangladesh.
• Pharmacovigilance Services Patient safety services including rigorous market monitoring and adverse drug reaction reporting aligned with WHO standards, mitigating health risks and ensuring product quality for distributed pharmaceuticals in Bangladesh.
• Medical Device Import and Supply Import and supply of medical devices into the Bangladesh market, consistent with the firm's broader role as a healthcare product importer serving healthcare providers and institutions.

Quantifiable outcome

• 70+ global partnerships enabling access to niche pharmaceutical molecules

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered core.

• OMRON Healthcare BangladeshcoreStrategic or Co-development PartnerZAS Corporation collaborates with OMRON Healthcare Bangladesh on healthcare solutions. The companies joined global team at FY'26 Kick-Off Meeting, indicating a strategic partnership focused on healthcare product distribution and market development.
• Global Pharmaceutical PartnerscoreOthersZAS Corporation maintains 70+ global partnerships across 40+ countries including Germany, Japan, Switzerland, USA, France, Italy, Spain, UK, Korea, China, Canada, Denmark, Malaysia, India, Australia, Sweden, Taiwan, and Turkey for importing niche pharmaceutical molecules.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• DKSH: Asia's largest market expansion services company with significant pharmaceutical distribution operations. Comparable as a pharmaceutical importer and distributor operating across multiple Asian emerging markets, though at substantially larger scale than ZAS.
• Renata Limited: Diversified Bangladeshi pharmaceutical company with animal health and human pharma operations. Comparable as a Bangladesh pharma operator with broad therapeutic area coverage, though Renata is a manufacturer rather than pure importer.
• Square Pharmaceuticals: Bangladesh's largest pharmaceutical manufacturer and distributor. Comparable as a Bangladesh-based pharma operator with both manufacturing and broad distribution capabilities, though it is significantly larger and operates across all therapeutic areas rather than specializing in niche imports.
• ACI Limited: Diversified Bangladeshi conglomerate with significant pharmaceutical and consumer health operations. Comparable as a Bangladesh healthcare distribution operator with adjacent verticals like ZAS's group structure.
• Eskayef Pharmaceuticals: Bangladesh pharmaceutical manufacturer with strong presence in specialty therapeutic categories. Comparable as a Bangladesh-based pharma operator with overlapping niche molecule focus, though Eskayef is primarily a manufacturer.
• Incepta Pharmaceuticals: One of Bangladesh's top pharmaceutical manufacturers with a large domestic and export footprint. Comparable as a vertically integrated Bangladesh pharma operator, though Incepta's scale exceeds ZAS's import-focused model.
• Zuellig Pharma: Pan-Asian pharmaceutical distribution and services company. Comparable as a regional pharmaceutical distributor with GDP-compliant logistics and multinational pharma partnerships, though serving broader geographies than ZAS's Bangladesh focus.
• Beximco Pharmaceuticals: Major Bangladeshi pharmaceutical manufacturer with growing export operations. Comparable as a leading Bangladesh pharma player with a broad product portfolio, though Beximco emphasizes manufacturing over ZAS's pure-play import and distribution model.

Direct peers

• Healthcare Pharmaceuticals: Bangladesh-based pharmaceutical manufacturer and importer specializing in niche therapeutic areas. Comparable as a similarly-sized Bangladesh pharma player with focus on imported specialty molecules and ethical marketing.
• Drug International Limited: Bangladesh-based pharmaceutical manufacturer and importer with a focus on specialty products. Most comparable as a similarly-sized Bangladesh pharma operator that combines local manufacturing with imported specialty molecules.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@zascorporationltd
• Facebookfacebook.com/Zascorporation
• LinkedInlinkedin.com/company/zas-corporation
• Instagraminstagram.com/zascorporationltd

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ZAS